Verinata Health Publishes Validation Study of Sequencing-Based Trisomy Test
April 26, 2011
Verinata Health Publishes Validation Study of Sequencing-Based Trisomy Test
Using a sequencing method and proprietary algorithm based on technology licensed from Stephen Quake at Stanford University, the researchers correctly identified all trisomy 21 and trisomy 18 cases.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Quake Group Issued Patent for Detection of Fetal Aneuploidy with Next-Gen Sequencing
August 31, 2011 / Clinical Sequencing News - Sequenom Says Competitors Will Have to License IP for Noninvasive T21 Detection Tests
July 27, 2011 / Clinical Sequencing News - Building on Trisomy 21 Test, Hong Kong Team Develops Method to Detect T13 and T18
July 6, 2011 / Clinical Sequencing News - LifeCodexx Begins Clinical Validation Study of Sequencing-Based T21 Test
June 29, 2011 / Clinical Sequencing News - Sequencing-Based Fetal Testing Market Heats up as Verinata Plans 2012 Launch for Down Syndrome Dx
May 4, 2011 / Clinical Sequencing News